Clinical Pediatric Endocrinology
Online ISSN : 1347-7358
Print ISSN : 0918-5739
ISSN-L : 0918-5739
Treatment of Uremic Children in Japan with Recombinant Human Growth Hormone (r-hGH)
Katsumi ItoHiroshi KawaguchiJapanese Multi-Center Open Study Group
Author information
JOURNAL FREE ACCESS

1994 Volume 3 Issue Supple4 Pages 37-40

Details
Abstract
We treated 93 children suffering from chronic renal failure with recombinant human growth hormone (r-hGH) for 6 months to improve their growth retardation due to uremia. They were divided into two groups, non-dialyzed and dialyzed children. The dose of r-hGH was 0.5IU/kg/week in non-dialyzed and either 0.5 or 1.0IU/kg/week in dialyzed children. After 6 months of treatment with r-hGH, growth velocity was significantly increased in both groups. Growth velocity was stimulated to about twice as much as before treatment. No severe side-effect was noted, and no disturbance of renal function. The results of our study were consistent with those from Europe and USA. We conclude that r-hGH treatment is effective in improving retarded growth in children with renal disease, in Japan as elsewhere.
Content from these authors
© The Japanese Society for Pediatric Endocrinology
Previous article Next article
feedback
Top